The presence of this medication in Oz is generating significant interest within the weight loss community. This novel dual medication – acting on both GLP-1 and GIP targets – shows a seemingly effective approach https://dirstop.com/story30060149/new-retatrutide-australia-the-fresh-approach-for-body-management